Irvine, CA, United States of America

Vance Gardner

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Vance Gardner: Innovator in Angiogenic Treatment

Introduction

Vance Gardner is a notable inventor based in Irvine, CA, who has made significant contributions to the field of medical technology. With a total of 7 patents to his name, Gardner's work primarily focuses on innovative systems and methods for treating ischemic tissues.

Latest Patents

Among his latest patents, Gardner has developed systems and methods for angiogenic treatment in wound healing. This invention addresses the diagnosis, amelioration, and treatment of ischemic tissues in patients suffering from diminished microvascular blood flow. His approach categorizes patients into specific subsets that may respond positively to therapy. The invention includes various therapies aimed at stimulating angiogenesis, vasculogenesis, arteriogenesis, and neovascularization to enhance tissue perfusion. Another significant patent involves therapeutic angiogenesis for treating spinal conditions, degenerative disc disease, and back pain. This method also categorizes patients with ischemic spine disease into subsets that may benefit from targeted therapies.

Career Highlights

Throughout his career, Gardner has worked with various organizations, including Cardiovascular Biotherapeutics, Inc. His innovative contributions have positioned him as a key figure in the development of advanced medical treatments.

Collaborations

Gardner has collaborated with notable professionals in his field, including John W. Jacobs and Kenneth A. Thomas. These partnerships have further enriched his research and development efforts.

Conclusion

Vance Gardner's work in angiogenic treatment showcases his dedication to improving patient outcomes through innovative medical solutions. His patents reflect a commitment to addressing complex health issues, particularly in the realm of ischemic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…